Skip to main content
SpringerLink
Log in

Evaluating the Balance of Persuasive and Informative Content within Product-Specific Print Direct-to-Consumer Ads

  • Medical Communication
  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

Abstract

This study attempts to compare the prevalence of persuasive and informative appeals found in direct-to-consumer (DTC) ads of prescription drugs in consumer magazines. A content analysis of DTC ads in a stratified randomized sample of magazines published from 1995 to 2000 identified the use of 10 types of persuasive appeals and 12 types of informative appeals. The average ad employed the use of 6.24 informative appeals and 3.13 persuasive appeals. DTC ads in magazines with a predominately male readership were found to contain a greater number of persuasive appeals than ads in other magazines. While the products most frequently advertised were for chronic nonlife-threatening conditions, a panel of pharmacists evaluated the majority of these products as having a high degree of clinical usefulness. Despite significant differences in the prevalence of certain types of appeals among ads for different products, the balance of persuasive and informative appeals did not vary considerably among them. Ads for drugs judged to be more specious in clinical usefulness did not employ the use of additional persuasive appeals and were found to be just as informative as ads for other drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Penick TM. New trends in direct-to-consumer advertising: The Actigall® campaign. J Pharm Market Manag. 1993;7(3):9–107.

    Google Scholar 

  2. Perri M, Nelson AA Jr. An exploratory analysis of consumer recognition of direct-to-consumer advertising of prescription medications. J Health Care Market. 1987;7(1):9–17.

    CAS  Google Scholar 

  3. Lipton C. Consumer advertising and pharmaceuticals: A happy marriage? J Pharm Market Manag. 1993;7(2)25–28.

    Google Scholar 

  4. Winters P. Prescription drug ads up: Information-hungry boomers to fuel continued growth. Advertise Age. 1993;64:37.

    Google Scholar 

  5. Keith A. Information matters: The consumer as the integrated health care system. In Manning RL, Masia NA (eds.). Prescription Drug Advertising: Empowering Consumer Through Information. New York, NY: Pfizer, Inc.; 2001.

    Google Scholar 

  6. Pinto MB, Pinto JK, Barber JC. The impact of pharmaceutical direct advertising: Opportunities and obstructions. Health Market Quart. 1998;15(4):89–101.

    Article  CAS  Google Scholar 

  7. Hunt M. Direct-to-consumer advertising of prescription drugs. Presented at the National Health Policy Forum, April 1998, The George Washington University, Washington, DC.

    Google Scholar 

  8. Desselle SP, Aparasu R. Attitudinal dimensions that determine pharmacists’ decisions to support DTCA of prescription medications. Drug Inf J. 2000;34:103–114.

    Article  Google Scholar 

  9. The Internet Revolution. In Giorgianni SJ (ed.). The Pfizer Journal, E-Health Care, The Internet Information Revolution. New York, NY: Impact Communications; 2000:4–7.

  10. Smith Barney Research. The New Women’s Movement: Women’s Healthcare. New York, NY: Smith Barney Research; April 1997.

    Google Scholar 

  11. Levy S. Study finds strong consumer awareness of DTC Rx ads. Drug Topics. 2000;13:47.

    Google Scholar 

  12. Parker BJ, Delene LM. Direct-to-consumer prescription drug advertising: content analysis and public policy implications. J Pharm Market Manag. 1998;12(4):27–42.

    Google Scholar 

  13. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs to consumers. N Engl J Med. 2002;346(7):498–505.

    Article  PubMed  Google Scholar 

  14. Trends in direct-to-consumer advertising of prescription drugs. Kaiser Family Foundation. Available at http://www.kff.org/content/2002/3162/. Accessed November 29, 2002.

  15. Heffler S, Levit K, Smith S, Smith C, Cowan C, Lazen H. Health spending growth up in 1999: faster growth expected in the future. Health Aff. 2001;20:193–203.

    Article  CAS  Google Scholar 

  16. IMS HEALTH Integrated Promotional Services; Competitive Media Reporting. US Total Promotional Spending by Type, 2000. Available at http://www.imshealth.com/public/structure/dispcontent/1,2779,1343-1343-143223.00.html. Accessed November 29, 2002.

  17. IMS HEALTH Integrated Promotional Services; Competitive Media Reporting. US Total Promotional Spending by type, 2001. Available at http://www.imshealth.com/public/structure/dispcontent/1,2779,1343-1343-144077.00.html. Accessed November 29, 2002.

  18. Maddox LM, Katsanis LP. Direct-to-consumer advertising of prescription drugs in Canada: Its potential effect on patient-physician interaction. J Pharm Market Manag. 1997;12(1) 1–21.

    Article  Google Scholar 

  19. Kemper DW, Mettler M. A consumer-empowered response to direct-to-consumer advertising of prescription drugs. Manag Care Quar. 2002;10(2):52–54.

    Google Scholar 

  20. Anon. Americans at risk from self-medication, survey reveals. Am J Health-Syst Pharm. 1997; 54:2664–2666.

    Google Scholar 

  21. Roth MS. Patterns in direct-to-consumer prescription drug print advertising and their public policy implications. J Pub Policy Market. 1996; 15(1):63–75.

    Article  Google Scholar 

  22. Craig RP. The patient as a partner in prescribing: direct-to-consumer advertising. J Man Care Pharm. 1998;4(1):15–19.

    Article  Google Scholar 

  23. Center for Drug Evaluation and Research. Guidance for Industry, Available al http://www.fda.gov/cder/guidance/1804fnl.htm. Accessed December 2, 2002.

  24. Sullivan D. Patient Understanding of the Brief Summary Information in Direct-to-Consumer Advertising of Prescription Drugs. Presented at the American Pharmaceutical Association Annual Meeting, March 15–19, 2002, Philadelphia, PA.

  25. Cady PS, Larson LN. Brief summary and the believability of consumer prescription drug advertising. J Pharm Market Manag. 1989;3(4):65–72.

    Article  Google Scholar 

  26. Smith DL. Consumers call for clarity in DTC ads. Pharm Exec. 1999;19(11):116.

    Google Scholar 

  27. Conlan MF. Many consumer ill-informed about Rxs, says AARP. Drug Topics. 2000;11:20.

    Google Scholar 

  28. Sumpradit N, Ascione F, Bagozzi R. A cross-media content analysis of direct-to-consumer prescription drug advertising (DTCA). Presented at the American Pharmaceutical Association Annual Meeting, March 15–19, 2002, Philadelphia, PA.

  29. Pinto MB. On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs. Psych Rep. 2000; 86:597–607.

    Article  CAS  Google Scholar 

  30. Woloshin S, Schwartz LM, Tremmel J, Welch HG. Direct-to-consumer advertisements for prescription drugs: What arc Americans being sold? Lancet. 2000;358:1141–1146.

    Article  Google Scholar 

  31. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Aff. 2000;19:110–128.

    Article  CAS  Google Scholar 

  32. National Institute for Health Care Management. Washington, DC: Prescription Drugs anil Mass Media Advertising. Washington, DC: National Institute for Health Care Management; September 2000.

    Google Scholar 

  33. Manning R, Keith A. The economics of direct-to-consumer advertising of prescription drugs. In Manning RL, Masia NA (eds.). Prescription Drug Advertising: Empowering Consumers Through Information. New York, NY: Pfizer. Inc., 2001.

    Google Scholar 

  34. Sheffet MJ, Kopp SW. Advertising prescription drugs to the public: Headache or relief? J Public Policy Market. 1990;9:42–61.

    Article  Google Scholar 

  35. Choices II Database version 6.0c. New York, NY: Simmons Market Research Bureau: August 1999.

  36. Aday LA. Deciding how Many will be in a Sample. Designing and Conducting Health Surveys: A Comprehensive Guide. San Francisco, CA: Jossey-Bass; 1996.

    Google Scholar 

  37. Hoog S. Over-the-counter drug advertising; Argumentation or persuasion. J Pharm Market Manag. 1994; 9(2): 69–91.

    Article  Google Scholar 

  38. SPSS Base 10.0 User’s Guide. Chicago, IL: SPSS, Inc.; 1999.

  39. Rust RT, Cooil B. Reliability measures for qualitative data: Theory and implications. J Market Res. 1994;(Feb):1–14.

  40. Stone TR, Warren WE, Stevens RE. Segmenting the mental health care market. J Health Care Market. 1990;10(1):65–69.

    CAS  Google Scholar 

  41. Christiansen TP, Ascione FJ, Bagozzi RP. Understanding how elderly patients process drug information: A test of information processing. Pharm Res. 1997;14:1589–96.

    Article  Google Scholar 

  42. Bradley LR, Zito JM. Direct-to-consumer prescription drug advertising. Med Care. 1997;35(1):86–92.

    Article  CAS  PubMed  Google Scholar 

  43. Choi Y, Thorson E. Memory for factual, emotional, and balanced ads under two instructional sets. In Fletcher, AD (ed.). Proceedings of the 1983 Conference of the American Academy of Advertising. Knoxville, TN: University of Tennessee; 1983.

    Google Scholar 

  44. Goldberg, ME, Gorn GJ. Happy and sad TV programs: how they affect reactions to commercials. J Consum Res. 1987;14:387–403.

    Article  Google Scholar 

  45. Page TJ, Thorson E, Heide MP. The memory impact of commercials varying in emotional appeal and product involvement. In Agres SJ, Edell JA, Dubitsky TM (eds.) Emotion in Advertising. New York, NY: Quorum Books; 1990.

    Google Scholar 

  46. Unwin S. Customized communications-a concept for service advertising. Advertise Quart. 1975;44:28–30.

    Google Scholar 

  47. Albers-Miller ND, Stafford MR. An international analysis of emotional and rational appeals in services vs goods advertising. J Consum Market. 1999;16(1):42–57.

    Article  Google Scholar 

  48. Cutler BD, Javalgi RG, Analysis of print ad features: Services versus products. J Advertise Res. 1993;33(2):62–70.

    Google Scholar 

  49. Dube L, Chattopadhyay A, Letarte A. Should advertising appeals match the basis of consumers’ attitudes? J Advertise Res. 1996;36(6):82–89.

    Google Scholar 

  50. Biswas A, Olsen JE, Carlet V. A comparison of print advertisements from the United States and France. J Advertise. 1992;21(4):73–81.

    Article  Google Scholar 

  51. Srivastava T, Schoenbachler DD. An examination of the information and thematic content of consumer print advertising in India. J Int Consum Market. 1999;12(2):63–85.

    Article  Google Scholar 

  52. Sciulli LM, Taiani V. Advertising content for the global audience: A research proposal. Competitive Rev. 2001;11(2):39–47.

    Article  Google Scholar 

  53. Turley LW, Kelley SW. A comparison of advertising content: Business to business versus consumer services. J Advertise. 1997;26(4):39–48.

    Article  Google Scholar 

  54. Smith MC, Visconti JA. Appeals used in prescription drug advertising. Hosp Pharm. 1968;3(2):5–13.

    Google Scholar 

  55. Wechsler J. Advertising under attack. Pharm Exec. 2000;20(7):26–34.

    Google Scholar 

  56. Shah MS, Holmes ER, Desselle SP. The use of persuasion in print DTC advertisements of prescription drugs: A content analysis of leading consumer magazines from 1995–2000. J Pharma Market Manag. 2003;15(3):23–43.

    Google Scholar 

Download references

Author information

Author notes

  1. Erin R. Holmes PharmD (MS Candidate)

    Present address: University of Mississippi School of Pharmacy, Faser Hall, Room 211, PO Box 1848, 38677-1848, University, MS, USA

Authors and Affiliations

  1. Division of Clinical, Social, and Administrative Sciences, Mylan School of Pharmacy, Duquesne University, Pittsburgh, Pennsylvania, USA

    Erin R. Holmes PharmD (MS Candidate)

  2. Office of Assessment and Educational Strategies, Mylan School of Pharmacy, Duquesne University, Pittsburgh, Pennsylvania, USA

    Shane P. Desselle PhD (Director, Associate Professor)

  3. Mylan School of Pharmacy, Duquesne University, Pittsburgh, Pennsylvania, USA

    Shane P. Desselle PhD (Director, Associate Professor)

Authors
  1. Erin R. Holmes PharmD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shane P. Desselle PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erin R. Holmes PharmD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holmes, E.R., Desselle, S.P. Evaluating the Balance of Persuasive and Informative Content within Product-Specific Print Direct-to-Consumer Ads. Ther Innov Regul Sci 38, 83–98 (2004). https://doi.org/10.1177/009286150403800111

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286150403800111

Key Words

Search

Navigation